Reduction of the taxable amount – Agreement between pharmaceutical company and health insurer
Is a national rule under which a pharmaceutical undertaking which makes payments to a public health insurer on the basis of turnover from the sale of medicinal products under a voluntary agreement is not entitled to reduce the taxable amount retrospectively contrary to Article 90(1) of the Directive?
Unofficial translation. More information/source documents expected later.
Latest Posts in "European Union"
- EU Operation Goliath: EPPO Secures Germany’s First Criminal Organization Conviction in €200M VAT Fraud
- EU Parliament Calls for Stronger Coordination Against VAT Fraud
- EU backs anti-VAT fraud measures extension until 2030
- EU Launches NCTS Phase 6 for Modernized Customs and Transit Procedures
- ECJ Customs C-844/24 (Labroix) – ECJ Allows EU-Wide Statistical Prices for Customs Valuation Only as a Last Resort
